QR код

Comparative bioequivalence of 1 mg and 4 mg tacrolimus extended-release tablets: randomized, open label, fully replicate, crossover trials in healthy adult subjects

IntroductionThese studies were planned to establish bioequivalence between two doses (1-mg and 4-mg) of test product (tacrolimus extended-release tablets manufactured by Intas Pharmaceuticals Ltd., India) with reference product (Envarsus XR® manufactured for Veloxis Pharmaceuticals, Inc., USA).Metho...

Бүрэн тодорхойлолт

-д хадгалсан:
Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Jay Kumar Sharma, Deepak Bunger, Hemant Zaveri, Alok Chaturvedi
Формат: Artigo
Хэл сонгох:Inglês
Хэвлэсэн: Frontiers Media S.A. 2026-06-01
Цуврал:Frontiers in Nephrology
Нөхцлүүд:
Онлайн хандалт:https://www.frontiersin.org/articles/10.3389/fneph.2026.1838510/full
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!